Brought to you by:
ABRE subanalysis highlights obesity ‘paradox’ in post-venous stenting outcomes
Results from a subset analysis of the ABRE study have shown that patients in three out of the six World Health Organisation (WHO) body mass index (BMI) groups—‘pre-obesity’, ‘obesity class I’ and ‘obesity class II’—trended towards higher 36-month patency rates…
CEA: The importance of doctor-patient conversations about quitting smoking for better stroke outcomes in setting of asymptomatic stenosis
A new analysis that shows current smokers who undergo carotid endarterectomy (CEA) for asymptomatic carotid stenosis are at increased risk of long-term stroke and death compared to former or never smokers helps reinforce the importance of physicians talking to patients…
Hybrid aortic arch: ‘We believe there is still a role for a versatile multiple-branched arch option’
Mid-term results from an analysis of a series of hybrid aortic arch reconstructions utilizing overlapping single thoracic branch endoprostheses in a dual-branch configuration showed the technique to be safe and versatile. Delivered at the 2024 Western Vascular Society (WVS) annual…
Female patients found to be at increased risk from adverse outcomes after an ALI diagnosis
Results from a new study highlighting that female patients are at increased risk of adverse outcomes after acute limb ischemia (ALI) lend weight to the possibility of underdiagnosis and management of vascular disease among women, the authors behind the research…
Study details aspects of early care improvements after publication of SVS appropriate use criteria for claudication
An observational study of intermittent claudication (IC) practice patterns before and after publication of the Society for Vascular Surgery (SVS) appropriate use criteria (AUC) for IC management points to a series of areas where care has improved, alongside aspects still…
Endospan completes enrolment of primary arm in TRIOMPHE IDE clinical study
Endospan today announced the completion of enrolment for the primary arm of its TRIOMPHE investigational device exemption (IDE) clinical study investigating the Nexus aortic arch stent graft. The study is evaluating the safety and efficacy of the device for the…
CVRx announces new CPT Category I codes for Barostim baroreflex activation therapy
CVRx, the company behind the Barostim baroreflex activation therapy system, recently announced that the American Medical Association (AMA) has accepted new Current Procedural Terminology (CPT) Category I codes for the device, which treats the symptoms of heart failure. The decision…
SVS member picks up prestigious American Heart Association accolade for scientific work
A prominent surgeon-scientist and Society for Vascular Surgery (SVS) member is the 2024 recipient of the American Heart Association (AHA) Joseph A. Vita Award, which recognizes published work that has had a transformative impact on basic, translational or clinical cardiovascular…
Novel RCT framework set to improve design and reporting of endovascular infrainguinal lower-limb interventions for PAD
Pilot testing has shown that a new framework—dubbed Endo-STAR—can be used to describe and standardise endovascular interventions for peripheral arterial disease (PAD) within a randomised controlled trial (RCT) protocol and monitor adherence to the protocol over the course of a…
Pulse IVL system US pivotal trial enrolls first patient
Amplitude Vascular Systems (AVS) recently announced that it has enrolled the first patient in its U.S. pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy. A press release notes that the POWER PAD II clinical study will evaluate the safety and…